WishBone Medical acquired substantially all assets of Back 2 Basics Direct and Orbbö Surgical, medical device companies focused on research, development and commercialization of sterile packaged implants and instruments for spinal fusion.
Back 2 Basics was founded in 2015 by orthopedic spine surgeons. The company offers sterile packaged spine implants such as the eCarbon Anterior Cervical Interbody Fusion Cage and the Dymaxeon® Pedicle Fixation Spine System. Go-to-market plans include the addition of B2B’s enhanced carbon composite biomaterials platform to WishBone's product development portfolio.
Orbbö Surgical offers a sterile packaged business model designed to reduce the risk of post-operative infection and increase operational efficiency within hospitals and ambulatory surgical centers.
“These acquisitions strengthen WishBone’s position in the pediatric orthopedic market with the addition of nine FDA cleared, sterile packaged, spinal fusion product lines with year one revenue projections in excess of $12 million,” said Dr. Robert Wertz, Global Vice President of Market Development, Spine & Sports Medicine, WishBone Medical.
Kevin Blue, Chief Revenue Officer of WishBone Medical, added, “Our entry into the pediatric spine segment marks yet another important milestone in our company’s history. We’re always looking to provide highly differentiated products that deliver clinical benefits with the potential to dramatically improve the lives of pediatric patients worldwide. These latest transactions will continue to position WishBone as the leading provider of sterile packed, anatomically appropriate procedure kits in the wake of the COVID-19 era.”